Dr Kannan Vishwanatth of Rupus Global Limited

On 6th September, the Supreme Court of India refused to permit Ravi Ruia, promoter of the giant Essar group of companies to travel abroad. Here’s what a bench of Justices JS Khehar and Arun Mishra said while rejecting his plea. “We have allowed a person to go abroad but he never came back. He was no less big than you in monetary terms. We don’t want to take chances now. We are now once bitten twice shy. We are not going to give liberty to anyone.” 

The apex court’s tough stance is heartening for investors and creditors. Promoters of a slew of Indian companies can remain overseas indefinitely because they have plenty of funds stashed abroad. These funds have been siphoned out of their Indian businesses or raised from money circulation schemes that robbed the rich and poor alike. The Pearls Agro Tech Corporation (PACL), which has been asked by the market regulator to refund a stupendous Rs 49,000 crore, has large assets in Australia and a few other countries. The Sahara group, built on alleged investments by India’s poorest people, has assets in the form of luxury hotels around the world including Macedonia. Subrata Roy’s wife and son are even understood to have acquired citizenship of the Republic of Macedonia. 

If this is the case with high-profile and flamboyant businessmen, smaller industrialists with dubious track records are not far behind in diverting funds to build nest eggs abroad. 

Investors faced with huge losses are ending up playing sleuth and setting up groups or associations to track the flow of funds, file cases, or merely support one another, in an effort to recover their investment. This has happened in the case of shady companies like PACL and QNet as well as with smaller listed companies where people have lost a lot of money. The Sahara group is the only exception where no investor seems concerned at the fate of her investment, raising another set of questions about who really invested in its schemes. 

Often, such investor groups do manage to track the fraudulent diversion of funds from listed entities; but their effort is, eventually, frustrated by the tediously slow investigation and judicial process. A good example is that of Dr Datsons Lab, a little-known pharma company that was allowed to run, what seems like, a money laundering and price manipulation operation, right until 22 May 2015 when the two all-India stock exchanges, finally, suspended the shares.
This was a month after its bankers had obtained a court order putting the company into liquidation, had taken possession of its registered office (which was owned by the promoter Dr Kannan K Vishwanatth) and invoked 100% of the promoter’s shareholding which was pledged with banks. And, yet, this company had managed to fool people with a massive investment from foreign institutional investors (who held 56% of its equity at one time) and ‘winning’ a series of awards for good governance, innovation, transformation and leadership! 

Dr Datsons Lab (DDL) is a fit case for investigation under the draconian Prevention of Money Laundering Act (PMLA); but we see no sign of any such action. Instead, a group of investors continues to ferret out information about the promoter’s latest antics and write to the government pleading for action. 

In a letter to the finance minister, an investor, Lt Commander Joginder Pal Kanaujia, has listed seven frauds by DDL’s former promoter Prof. Dr Kannan Vishwanatth. He has painstakingly compiled this information, along with a group of investors, over the past 15 months. Each instance of fraud, mentioned in the letter, is accompanied by some evidence in the form of court judgements, patent registration details, or mirror companies set up by the promoter (mirror companies are entities with similar names set up in different countries to obfuscate facts and fool regulators and investigation agencies). Lt Commander Kanaujia has sought an investigation by the Central Bureau of Investigation (CBI) to bring back Rs250 crore of DDL investors’ money which he believes was siphoned off to Hong Kong through a laundering operation. Here are some interesting questions raised by the letter.

When DDL was first listed on the bourses, its IPO (initial public offer) document had disclosed that a part of the issue proceeds would be used to repay its bankers, State Bank of India and Shamrao Vithal Bank, and Rs10 crore of unsecured loans from directors. It now turns out that a ‘consortium’ of bankers, led by Bank of Baroda, had gone ahead and funded its plants which are now being sold to recover money. One can understand investors being lazy and foolish and failing to read a prospectus. But isn’t it time we, as a country, begin to act against public sector bankers who extended fresh loans to DDL without adequate monitoring, when the disclosures in its offer documents proclaimed its shady character?

The risk factors in the IPO document had clearly stated that it had negative cash flows at the time of the issue, had placed no orders for plant & machinery and the object for which funds were raised was not appraised by any bank or institution. Worse, many of its trademarks were also not registered in the company’s name but were held by the promoter. Why would Bank of Baroda lend to this company after project appraisal officers had read the stinking prospectus? The answer is obvious; but is anyone asking questions?

Has the tax department sent any notices at all to Dr Kannan Vishwanath under the PMLA or obtained information that is being shared by its investors about his brand new Hong Kong-based company called Windsonn Exim Ltd? This company claims to hold the same 15 patents that once belonged to a wholly-owned subsidiary called Fair Success HK Ltd which was acquired by Dr Datsons Lab after fund raising.

Which lender or government agency will be authorised to secure overseas assets of DDL such as the follaowing wholly-owned subsidiaries –Eros Pharmachem Pte (Singapore), Aanj Pharmalabs Limited Fze (Dubai), Dr Datsons Labs Limited (UK) and Fair Success (HK) Limited? Of these, Fair Success apparently has Rs80 crore in its bank account.Unless this government makes a break from the past and holds public sector bankers accountable for corrupt and collusive lending, the mountain of bad loans, which are eventually paid by the taxpayer, will continue to mount. When large lenders collude with fraudulent promoters and allow them to strip cash and assets from the company, they also deal a crippling blow to investors and unsecured creditors. This has been going on for the past several decades; unfortunately, there is no sign that things will change even under this government. A focus on a few big names like Mr Mallya and Mr Ruia only ensures that hundreds of such cases fly below the radars of multiple investigative agencies tasked to bring financial criminals to book.

More On Dr Kannan Vishwanatth:

Fact About Kannan Vishwanatth’s BSE Listed Pharma

How Kashi Vishwanath and his son Dr Kannan Vishwanath defrauded


Frauds Commited By Dr Kannan Vishwanatth[Rupus Global Limited]